肿瘤标志物SCC-Ag、Cyf21-1、CEA、ProGRP、及NSE联合检测在肺癌诊断中的应用

详细信息    查看全文 | 推荐本文 |

英文篇名：Application of combined detection of tumor markers,SCC-Ag,cyf21-1,CEA,ProGRP,and NSE in the diagnosis of lung cancer 作者：董芸 ; 袁峥玺 ; 姚原 英文作者：DONG Yun;YUAN Zheng-xi;YAO Yuan;Department of Radiation Oncology,NO.9 People Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; 关键词：SCC-Ag ; Cyf21-1 ; CEA ; ProGRP ; NSE ; 联合检测 ; 肺癌 英文关键词：SCC-Ag;;Cyf21-1;;CEA;;ProGRP;;NSE;;Combined diagnosis;;Lung cancer 中文刊名：ZSZD 英文刊名：Chinese Journal of Laboratory Diagnosis 机构：上海交通大学医学院附属第九人民医院放疗科; 出版日期：2019-03-25 出版单位：中国实验诊断学 年：2019 期：v.23 语种：中文; 页：ZSZD201903002 页数：3 CN：03 ISSN：22-1257/R 分类号：8-10

摘要

目的通过体外分析检测血清中鳞状细胞癌抗原(SCC-Ag)、细胞角蛋白19片段抗原(Cyf21-1)、癌胚抗原(CEA)、胃泌素释放肽前体(ProGRP)及神经元特异性烯醇化酶(NSE)5种肿瘤标志物在健康体检者、肺良性疾病和肺癌人群中含量的差异,分析五种肿瘤标志物联合检测的可行性。方法回顾性分析2015年1月到2018年7月我院相关科室收治明确诊断肺癌患者90例,肺良性病变患者90例,体检中心健康体检者90例。通过收集三组数据进行比较分析,对比5种肿瘤标志物独立诊断与联合诊断肺癌的敏感性和特异性。结果三组SCC-Ag、Cyf21-1、CEA、ProGRP、NSE含量差异具有统计学意义(P<0.05),健康对照组与肺癌组对比SCC-Ag、Cyf21-1、CEA、ProGRP、NSE含量差异具有统计学意义(P<0.05),肺良性病变组与肺癌组对比五种标志物含量差异具有统计学意义(P<0.05),小细胞肺癌组ProGRP、NSE水平明显高于非小细胞肺癌组差异具有统计学意义(P<0.05);SCC-Ag、Cyf21-1、CEA、ProGRP、NSE联合检测敏感性高于单独检测,但是联合检测特异性下降。结论 SCC-Ag、Cyf21-1、CEA、ProGRP、NSE在肺癌患者、健康体检者以及肺良性病变患者体内含量差异较为明显,五种肿瘤标志物的联合检测有利于肺癌早期鉴别诊断。
        Objective Detection of five types of tumors in serum:SCC-Ag,Cyf21-1,CEA,proGRP and NSE Differences in levels of markers in healthy health checkups,lung disease and lung cancer,The feasibility of joint detection of five tumor markers.Methods Retrospective analysis of 90 cases of lung cancer,90 cases of lung benign lesions,and 90 cases of physical examination center health examination from January 2015 to July 2018.Comparative analysis by collecting three sets of data,Sensitivity,specificity and accuracy of independent and combined diagnosis of five tumor markers in lung cancer.Results The contents of SCC-Ag,Cyf 21-1,CEA,ProGRP and NSE in three groups were statistically significant(P<0.05),The difference of SCC-Ag,Cyf 21-1,CEA,ProGRP and NSE was statistically significant in the control group and lung cancer group(P<0.05).The difference between lung benign lesions and lung cancer was statistically significant(P<0.05),ProGRP and NSE levels were significantly higher in small cell lung cancer group than in non-small cell lung cancer group(P<0.05),SCC-Ag,Cyf 21-1,CEA,ProGRP,NSE joint detection sensitivity are higher than individual detection,But the combination of tests showed a decrease in specificity.Conclusion SCC-Ag,Cyf 21-1,CEA,ProGRP,and NSE showed significant differences in the levels of lung cancer patients,health checkups,and lung benign lesions.The combined detection of five tumor markers was beneficial to the early differential diagnosis of lung cancer.

引文

[1]倪军,郭子健,张力.单独与联合检测四项肺癌血清肿瘤标志物在肺癌诊断中的价值[J].中华内科杂志,2016,55(1):25.
    [2]吴寒静,王凯,马卫红.血清肿瘤标志物NSE、SCC、CYFR21-1与CEA联合检测在肺癌诊断中的应用价值研究[J].国际检验医学杂志,2016,37(22):3218.
    [3]刘嘉林,何法霖,徐百友.血清肿瘤标志物在老年肺癌诊断的作用分析[J].中国地方病防治杂志,2014,29(S1):127.
    [4]金霞霞,陈世友,齐娟飞.血清NSE、ProGRP、CEA、SCCA和CY-FR21-1联检在肺癌诊断中的意义[J].放射免疫学杂志,2012,25(1):84.
    [5]Ferlay J,Soerjomataram I,Dikshit R,et al.Cancerincidence and mortality worldwide;sources,methods and major patternsin GLOBOCAN2012[J].Int J Cancer,2015,126(5):E359.
    [6]张青云.肿瘤标志物临床检测技术现状及发展趋势[J].中华检验医学杂志,2006,29(9):857.
    [7]杨婷,杨勤.肺癌血清肿瘤标志物的研究进展[J].中国药物与临床,2005,5(7):459.
    [8]杨栓盈,张王刚,孙秀珍,等.五种血清肿瘤标志物单个或联合检测在肺癌诊断作用的初步评价[J].西安交通大学学报:医学版,2005,26(4):352.
    [9]余文聘,郑小河.胃泌素释放肽前体在小细胞肺癌诊断中的研究进展[J].汕头大学医学院学报,2004,17(2):127.
    [10]Kato H,Torigoe T.Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma[J].cencer,1977,40:1621.
    [11]王光彦,李海燕,杨思俊,等.肿瘤标志物联合检测对良恶性胸腔积液的鉴别诊断[J].世界最新医学信息文摘,2016,16(103):137.
    [12]郑志村,钱进,朱伯金.多种肿瘤标志物蛋白芯片在消化道肿瘤中的检测及临床意义[J].安徽医学,2008,29(1):35.